TY  - CONF

T1  - Comparison of Cure Rates between Gemtuzumab Ozogamicin Plus Standard of Care Chemotherapy Vs Standard of Care Alone in Patients with Newly Diagnosed Acute Myeloid Leukemia

JO  - Blood

PY  - 2018/11/29

AU  - Muresan B

AU  - Mamolo CM

AU  - Cappelleri JC

AU  - Mokgokong R

AU  - Palaka A

AU  - Hills RK

AU  - Latimer N

AU  - Heeg B

ED  - 

DO  - DOI: 10.1182/blood-2018-99-110800

PB  - American Society of Hematology

VL  - 132

IS  - Supplement 1

SP  - 2712

EP  - 2712

Y2  - 2024/12/22

ER  -